Rare diseases
Investigational molecules
Locations
Back to the Netherlands326 clinical trials in Maastricht, The Netherlands across 6 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in the NetherlandsKlinischOnderzoek.nl(opens in a new tab)Study of Pembrolizumab and Chemotherapy for Patients with HR+/HER2- Advanced Breast Cancer
The NetherlandsStudy of Pembrolizumab and BCG for Patients with High-Risk Non-Muscle Invasive Bladder Cancer
The NetherlandsStudy on Milvexian and Drug Combination for Patients Recovering from a Heart Attack
The NetherlandsStudy of Tarlatamab and Durvalumab compared to Durvalumab alone for patients with extensive stage small cell lung cancer
The NetherlandsA Study Comparing Telisotuzumab Adizutecan to Trifluridine, Tipiracil, and Bevacizumab in Adults with Refractory Metastatic Colorectal Cancer
The NetherlandsStudy of Acasunlimab Alone and Combined With Pembrolizumab in Patients With Advanced Skin Melanoma That Returned or Did Not Respond to Prior Treatment
The NetherlandsStudy of tarlatamab with durvalumab, carboplatin and etoposide versus standard treatment in patients with previously untreated extensive stage small cell lung cancer
The NetherlandsStudy on the Effectiveness and Safety of Mifepristone 50 mg Weekly for Contraception in Women
The NetherlandsStudy Comparing Axatilimab to Best Available Therapy for Patients with Chronic Graft-Versus-Host Disease After Two or More Treatments
The NetherlandsStudy on the Safety and Effectiveness of Adalimumab as Initial Treatment for Newly Diagnosed Crohn's Disease Patients
The NetherlandsStudy to Evaluate the Safety and Effectiveness of Vutrisiran in Patients with Transthyretin Amyloidosis and Heart Disease
The NetherlandsStudy on Psilocybin's Effect on Pain in Fibromyalgia Patients
The NetherlandsThe busiest research cities in the country
What the registry says about research in the country
Innovative clinical trials focusing on colorectal cancer, breast cancer, and melanoma treatments. Studies include novel therapy combinations and personalized treatment approaches.
Particular emphasis on targeted therapies and treatment optimization for various cancer types.
Research focusing on chronic kidney disease, fibromyalgia, and inflammatory bowel conditions. Studies evaluate new therapeutic approaches and treatment combinations.
Emphasis on developing effective long-term management strategies for chronic conditions.
Investigations into peripheral arterial disease and cardiomyopathy treatments. Research includes innovative therapeutic approaches and preventive strategies.
Focus on improving patient outcomes through targeted interventions and preventive measures.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
